Table 3.
Estimate | SE | p-value | |
---|---|---|---|
β0 (Intercept) | 29.57 | 3.30 | <0.01 |
η1 (age) | −3.63 | 2.92 | 0.22 |
η2 (male) | −9.39 | 13.38 | 0.49 |
η3 (AfricanAmerican) | 1.04 | 11.52 | 0.93 |
η4 (Caucasian) | 1.09 | 8.17 | 0.89 |
β1 (time; stage one) | 1.39 | 0.32 | <0.01 |
β2 (time×A1; stage one) | −0.80 | 0.29 | <0.01 |
β3 (time; stage two) | 0.12 | 0.17 | 0.47 |
β4 (time×A1; stage two) | 0.20 | 0.18 | 0.27 |
β5 (time×A1A2; stage two) | −0.08 | 0.23 | 0.73 |
| |||
(BLI, INT) | 37.38 | 4.16 | <0.01 |
(BLI, BLI+AAC) | 38.68 | 4.99 | <0.01 |
(BLI+AAC, ·) | 50.84 | 4.27 | <0.01 |
(BLI, INT) vs (BLI, BLI+AAC) | −1.30 | 3.72 | 0.73 |
(BLI+AAC, ·) vs (BLI, BLI+AAC) | 12.16 | 5.43 | 0.03 |
(BLI+AAC, ·) vs (BLI, INT) | 13.46 | 5.02 | 0.01 |